Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue: +4.15%
EPS: +49.0%
Free cash flow: +49.8%
Total debt: +80.0%

Quarter to September 2026, against a year earlier

209.82 16.72 −7.38%

Follow ILMN

Alert me

Market cap: $31.5B
P/E: 35.6×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 8/9
Altman Z: 4.39
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Illumina, Inc. (ILMN) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Illumina, Inc. (ILMN) trades at a price to free cash flow of 30.4×. Over the past ten years it has ranged from 0.0× (September 2023) to 876× (August 2022); the current reading is higher than 19% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ILMN/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Illumina, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ILMN/metrics/price-to-free-cash-flow">Illumina, Inc. (ILMN) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	22.2×	(26.15%)
FY2024	30.1×	(60.44%)
FY2023	76.0×	—
FY2022	0.0×	—
FY2021	173×	184.32%
FY2020	60.8×	5.31%
FY2019	57.8×	11.14%
FY2018	52.0×	(10.68%)
FY2017	58.2×	56.08%
FY2016	37.3×	(16.41%)

Period	Price to free cash flow	Change
Sep 2026	39.7×	36.83%
Jun 2026	29.0×	47.39%
Mar 2026	19.7×	(11.40%)
Dec 2025	22.2×	50.45%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 876×

Ten-year median 54.6×

Current reading's percentile 19

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated compare	20.3×
IQV IQVIA Holdings Inc. compare	21.0×
LH Labcorp Holdings Inc. compare	25.4×
ILMN Illumina, Inc.	30.4×
A Agilent Technologies, Inc. compare	38.2×
MTD Mettler-Toledo International, Inc. compare	39.1×
IDXX IDEXX Laboratories, Inc. compare	40.6×
WAT Waters Corporation compare	173×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Illumina, Inc. (ILMN) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ILMN

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ILMN

Stockrow Weekly